| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/04/2009 | CN101360736A L-alanine derivatives |
| 02/04/2009 | CN101360735A Polymorphs of benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor |
| 02/04/2009 | CN101360714A Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies |
| 02/04/2009 | CN101360711A L-phenylalanine derivatives and its application as integrin antagonists |
| 02/04/2009 | CN101360707A Thrombopoietin activity modulating compounds and methods |
| 02/04/2009 | CN101357914A Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 02/04/2009 | CN100457735C Therapeutic agents useful for treating pain |
| 02/04/2009 | CN100457731C Benzamide modulators of metabotropic glutamate receptors |
| 02/04/2009 | CN100457730C Indoles having anti-diabetic activity |
| 02/04/2009 | CN100457728C Tyrosine kinase inhibitors |
| 02/04/2009 | CN100457719C Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 02/03/2009 | US7485732 Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| 02/03/2009 | US7485727 4-Phenoxy-, 4-phenylthio-, 4-phenylsulfonyl- or 5-phenylsulfinyl-1-(2-pyridinyl)piperidine derivatives; insecticides, miticides and nematocides |
| 02/03/2009 | US7485724 2,4-pyrimidinediamine compounds and their uses |
| 02/03/2009 | US7485664 Inhibitors of TACE |
| 02/03/2009 | US7485657 Anti-cytokine heterocyclic compounds |
| 02/03/2009 | US7485653 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
| 02/03/2009 | US7485652 Indolyl derivatives as liver-X-receptor (LXR) modulators |
| 02/03/2009 | US7485647 2-aminoquinoline derivatives |
| 02/03/2009 | US7485645 prostate cancer, benign prostatic hyperplasia, acne, seborrhea, hirsutism, androgenic alopecia, precocious puberty, adrenal hyperlasia and polycystic ovarian syndrome, breast cancer, endometriosis, leiomyoma and precocious puberty, estrogen dependent diseases |
| 02/03/2009 | US7485644 hydroxy{(1S)-4-pyrimidin-2-yl-1-[({4-[5-(2,2,2-trifluoroethoxy)pyrimidin-2-yl]piperazin-1-yl}sulfonyl)methyl]butyl}formamide; collagenase 3 inhibitor; tissue remodelling such as embryonic development, bone formation and uterine remodelling during menstruation |
| 02/03/2009 | US7485643 Bicyclic inhibitors of MEK and methods of use thereof |
| 02/03/2009 | US7485641 Substituted 3-amino-pyrrolidino-4-lactams |
| 02/03/2009 | US7485639 Well tolerated; intracellularly increasing cAMP; antiasthmatics, antiinflammatories: regulation of eosinophiles activation and degranulation |
| 02/03/2009 | US7485638 Pyrimidine compounds |
| 02/03/2009 | US7485625 Inhibitors of hepatitis C virus NS3/NS4a serine protease |
| 02/03/2009 | CA2478302C 9-aminoacridine derivatives and process for the preparation thereof |
| 02/03/2009 | CA2425164C (4-acylaminopiperidin-1-yl)acetamides as neurokinin antagonists |
| 02/03/2009 | CA2420040C New phenylalanine derivatives |
| 02/03/2009 | CA2384283C Process for preparing 4-trifluoromethylsulphinylpyrazole derivative |
| 02/03/2009 | CA2315050C Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof |
| 02/03/2009 | CA2274686C Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 01/29/2009 | WO2009015254A1 Triazine kinase inhibitors |
| 01/29/2009 | WO2009015166A1 Piperidine derivatives as modulators of chemokine receptor activity |
| 01/29/2009 | WO2009014910A2 N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the rup3 or gpr119 receptor for the treatment of diabetes and metabolic disorders |
| 01/29/2009 | WO2009014730A1 Macrocyclic serine protease inhibitors |
| 01/29/2009 | WO2009014674A1 Heterocyclylamides as gut microsomal triglyceride transport protein inhibitors |
| 01/29/2009 | WO2009014637A2 Heterocyclic amide compounds as protein kinase inhibitors |
| 01/29/2009 | WO2009014431A1 Selective production of sulphoxides |
| 01/29/2009 | WO2009014217A1 Bicyclic pyrrole derivative |
| 01/29/2009 | WO2009014150A1 Benzimidazole derivative |
| 01/29/2009 | WO2009013348A2 Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions |
| 01/29/2009 | WO2009013299A2 Novel bradykinin b1 antagonists |
| 01/29/2009 | WO2009013211A2 New pyrazol derivatives |
| 01/29/2009 | WO2009012656A1 Inhibitors for matrix metalloproteinases, pharmaceutical compositions containing them and their uses |
| 01/29/2009 | WO2008150481A3 Processes for the preparation of crystalline form beta of imatinib mesylate |
| 01/29/2009 | WO2008142528A3 An improved process for preparing nevirapine |
| 01/29/2009 | WO2008104278A8 Imidazo[1,2-a] pyridines and their use as pharmaceuticals |
| 01/29/2009 | WO2008092939A3 Process for the preparation of optically pure omeprazole via salt formation with a chiral amine or treatment with an entiomer converting enzyme and chromatographic separation |
| 01/29/2009 | WO2008060269A3 Quinoline methanol compounds for the treatment and prevention of parasitic infections |
| 01/29/2009 | WO2007144769A8 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
| 01/29/2009 | US20090030195 2-Oxo-3-[1-oxo-3-(2-trifluoromethylphenyl)-1,2-dihydroisoquinolin-7-yl]oxazolidin-5-ylmethyl(2-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}ethoxy)acetate; 7-(2-Oxoazetidin-1-yl)-3-(2-trifluoromethylphenyl)-2H-isoquinolin-1-one; anticarcinogenic agent ( solid cancer) |
| 01/29/2009 | US20090030044 Crystal of Salt of Benzimidazole Compound |
| 01/29/2009 | US20090030043 Potassium Channel Inhibitors |
| 01/29/2009 | US20090030042 Amide Addition Reaction |
| 01/29/2009 | US20090030040 Substituted Heterocyclic Ethers and Their Use in CNS Disorders |
| 01/29/2009 | US20090030039 Piperidine Derivatives as Cxcr3 Receptor Antagonists |
| 01/29/2009 | US20090030032 Bicyclic Compound, Production and Use Thereof |
| 01/29/2009 | US20090030023 Pyrimidine compounds and medicinal composition thereof |
| 01/29/2009 | US20090030021 Quinazoline Derivatives and Therapeutic Use Thereof |
| 01/29/2009 | US20090030018 Benzimidazole derivatives and their use for modulating the gabaalpha receptor complex |
| 01/29/2009 | US20090030016 Benzimidazole poly(adp ribose)polymerase inhibitors |
| 01/29/2009 | US20090030014 Indole Derivative Having Pgd2 Receptor Antagonist Activity |
| 01/29/2009 | US20090030013 Substituted tetrahydro-quinoline-sulfonamide compounds, their preparation and use as medicaments |
| 01/29/2009 | US20090030012 Pyridine, Pyrimidine and Pyrazine Derivatives as Cxcr3 Receptor Modulators |
| 01/29/2009 | US20090030000 Antiviral agents |
| 01/29/2009 | US20090029998 Thiazole Derivatives and Use Thereof |
| 01/29/2009 | US20090029997 Thiazole Derivatives and Use Thereof |
| 01/29/2009 | US20090029996 Pyridazin-3(2H)-One Derivatives And Their Use As Pde4 Inhibitors |
| 01/29/2009 | US20090029995 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 01/29/2009 | US20090029994 Trisubstituted amine compound |
| 01/29/2009 | US20090029991 Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/29/2009 | US20090029986 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia |
| 01/29/2009 | US20090029979 5-htx modulators |
| 01/29/2009 | US20090029976 e.g. [5-(1-cyclobutyl-piperidin-yloxy)-benzofuran-2-yl]-(4,4-difluoro-piperidin-1-yl)-methanone; antagonists and/or inverse agonists at the histamine 3 receptor (H3 receptor); antidepressant, antiepileptic agent, analgesic, anticonvulsant, motion seackness |
| 01/29/2009 | US20090029971 4-[2,6-Dimethyl-4-(4-trifluoromethoxy-phenyl)-piperazine-1-sulfonyl]-indan-2-carboxylic acid; peroxisome proliferator activated receptors modulator; antidiabetic, antiinflammatory agent; obesity, hyperinsulinemia, metabolic syndrome X, polycystic ovary syndrome, ischemia-associated organ injury |
| 01/29/2009 | US20090029965 Vasopressin V1a Antagonists |
| 01/29/2009 | US20090029963 Pyrazol derivatives |
| 01/29/2009 | US20090029863 Pesticides and uses thereof |
| 01/29/2009 | US20090029349 Chemiluminescence; quantitative analysis of macromolecules; complexing sample to acridinium compound, labels for improving sensitivity of immunoassays, 2',6'-dimethyl-4'-N-succinimidyloxycaproyl-amidocarbonylphenyl-N10-2,7-tris[O-methoxyhexa(ethylene) glycol-sulfonamidylpropyl]-acridinium-9-carboxylate |
| 01/29/2009 | US20090028821 Prodrugs of cc-a1065 analogs |
| 01/29/2009 | US20090028818 Heterocyclic antiviral compounds |
| 01/29/2009 | DE102007034620A1 Neue B1-Antagonisten New B1 antagonists |
| 01/29/2009 | CA2694275A1 Organic compounds |
| 01/29/2009 | CA2694251A1 Novel b1-antagonists |
| 01/29/2009 | CA2694216A1 Benzimidazole derivative |
| 01/29/2009 | CA2693967A1 Heterocyclic amide compounds as protein kinase inhibitors |
| 01/29/2009 | CA2693377A1 5-pyridinone substituted indazoles |
| 01/29/2009 | CA2693187A1 New pyrazol derivatives |
| 01/29/2009 | CA2693169A1 N-linked heterocyclic receptor agonists for the treatment of metabolic disorders |
| 01/28/2009 | EP2019101A1 Pyrazol[3,4-d]pyrimidin-4-one useful as Kinase Inhibitor |
| 01/28/2009 | EP2019100A1 Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators |
| 01/28/2009 | EP2019099A1 Dpp-IV inhibitors |
| 01/28/2009 | EP2019094A1 Heterocyclic type cinnamide derivative |
| 01/28/2009 | EP2019093A1 Urea type cinnamide derivative |
| 01/28/2009 | EP2018377A1 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial. |
| 01/28/2009 | EP2018376A1 Benzylamine derivatives as cetp inhibitors |
| 01/28/2009 | EP2018375A1 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial. |
| 01/28/2009 | EP2018371A1 Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 01/28/2009 | EP2018370A1 1,5-diphenylpyrazoles ii as hsp90 inhibitors |